Mazen W. Karaman

3.7k total citations · 1 hit paper
13 papers, 831 citations indexed

About

Mazen W. Karaman is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Mazen W. Karaman has authored 13 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Hematology. Recurrent topics in Mazen W. Karaman's work include Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Biochemical Analysis and Sensing Techniques (2 papers). Mazen W. Karaman is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Biochemical Analysis and Sensing Techniques (2 papers). Mazen W. Karaman collaborates with scholars based in United States and Canada. Mazen W. Karaman's co-authors include Joseph G. Hacia, Shripad S. Bhagwat, Michael F. Gardner, Patrick P. Zarrinkar, Merryl Cramer, Daniel Brigham, Hitesh Patel, Barbara Belli, Joyce James and Qi Chao and has published in prestigious journals such as Nucleic Acids Research, Blood and Cancer Research.

In The Last Decade

Mazen W. Karaman

13 papers receiving 813 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)

2009 474 citations Patrick P. Zarrinkar, Ruwanthi N. Gunawardane et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mazen W. Karaman United States	10	454	384	209	126	66	13	831
Melanie E. Davis United States	17	854 1.9×	132 0.3×	330 1.6×	202 1.6×	33 0.5×	24	1.1k
Marit Stirnberg Germany	19	328 0.7×	280 0.7×	244 1.2×	112 0.9×	16 0.2×	31	790
Celia Sigua United States	9	738 1.6×	266 0.7×	91 0.4×	143 1.1×	22 0.3×	15	948
James W. Bloom United States	14	349 0.8×	409 1.1×	121 0.6×	71 0.6×	81 1.2×	18	861
Vijay Menon United States	14	367 0.8×	126 0.3×	64 0.3×	139 1.1×	32 0.5×	28	593
Paul Tapang United States	14	444 1.0×	149 0.4×	79 0.4×	236 1.9×	39 0.6×	29	773
Catherine Tang United States	12	602 1.3×	234 0.6×	116 0.6×	201 1.6×	43 0.7×	16	1.1k
Joseph R. Garlich United States	17	735 1.6×	140 0.4×	115 0.6×	210 1.7×	121 1.8×	33	1.1k
Christina J. Allain United States	9	1.3k 2.8×	200 0.5×	35 0.2×	137 1.1×	85 1.3×	10	1.4k
Patrizia Carpinelli Italy	14	443 1.0×	125 0.3×	75 0.4×	337 2.7×	40 0.6×	25	762

Countries citing papers authored by Mazen W. Karaman

Since Specialization

Citations

This map shows the geographic impact of Mazen W. Karaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mazen W. Karaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mazen W. Karaman more than expected).

Fields of papers citing papers by Mazen W. Karaman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mazen W. Karaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mazen W. Karaman. The network helps show where Mazen W. Karaman may publish in the future.

Co-authorship network of co-authors of Mazen W. Karaman

This figure shows the co-authorship network connecting the top 25 collaborators of Mazen W. Karaman. A scholar is included among the top collaborators of Mazen W. Karaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mazen W. Karaman. Mazen W. Karaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Moser, Ann B., Jody Hey, Patricia Dranchak, et al.. (2013). Diverse captive non-human primates with phytanic acid-deficient diets rich in plant products have substantial phytanic acid levels in their red blood cells. Lipids in Health and Disease. 12(1). 10–10. 12 indexed citations

Watkins, Paul A., Ann B. Moser, Steven J. Steinberg, et al.. (2010). Identification of differences in human and great ape phytanic acid metabolism that could influence gene expression profiles and physiological functions. BMC Physiology. 10(1). 19–19. 25 indexed citations

Zarrinkar, Patrick P., Robert Armstrong, Ruwanthi N. Gunawardane, et al.. (2009). Abstract #1787: Characterization of the biochemical and cellular activity of the second-generation FLT3 inhibitor AC220. Cancer Research. 69. 1787–1787. 1 indexed citations

Zarrinkar, Patrick P., Ruwanthi N. Gunawardane, Merryl Cramer, et al.. (2009). AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). Blood. 114(14). 2984–2992. 474 indexed citations breakdown →

Zarrinkar, Patrick P., Robert C. Armstrong, Ruwanthi N. Gunawardane, et al.. (2008). AC220 Is a Uniquely Potent and Selective Second-Generation FLT3 Inhibitor. Blood. 112(11). 859–859. 1 indexed citations

Wang, Zhong, Philip Lecane, Qing Fan, et al.. (2007). Synthesis and biologic properties of hydrophilic sapphyrins, a new class of tumor-selective inhibitors of gene expression. Molecular Cancer. 6(1). 9–9. 29 indexed citations

Hacia, Joseph G., et al.. (2007). Age‐related gene expression profiles of rhesus monkey bone marrow‐derived mesenchymal stem cells. Journal of Cellular Biochemistry. 103(4). 1198–1210. 21 indexed citations

Nguyen, Dan C., et al.. (2007). Loss of p53 Expression Correlates with Metastatic Phenotype and Transcriptional Profile in a New Mouse Model of Head and Neck Cancer. Molecular Cancer Research. 5(4). 351–362. 31 indexed citations

Magda, Darren, Philip Lecane, Richard A. Miller, et al.. (2005). Motexafin Gadolinium Disrupts Zinc Metabolism in Human Cancer Cell Lines. Cancer Research. 65(9). 3837–3845. 53 indexed citations

10.

Karaman, Mazen W.. (2005). Comparisons of substitution, insertion and deletion probes for resequencing and mutational analysis using oligonucleotide microarrays. Nucleic Acids Research. 33(3). e33–e33. 35 indexed citations

11.

Lecane, Philip, Mazen W. Karaman, Mint Sirisawad, et al.. (2005). Motexafin Gadolinium and Zinc Induce Oxidative Stress Responses and Apoptosis in B-Cell Lymphoma Lines. Cancer Research. 65(24). 11676–11688. 58 indexed citations

12.

Karaman, Mazen W., Marlys L. Houck, Leona G. Chemnick, et al.. (2003). Comparative Analysis of Gene-Expression Patterns in Human and African Great Ape Cultured Fibroblasts. Genome Research. 13(7). 1619–1630. 89 indexed citations

13.

Karaman, Mazen W.. (2003). Genomes, 2nd edition. Journal of Heredity. 94(5). 432–a. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact